I actually think that if there's a TH it wont be related to the potential of the "Mystery Product", BTX1801. Data from the pre-clinical was included in the Outlook Presentation so that now the design for a Phase 1 trial, followed by the ethic approval, can go ahead.
By the way, it looks like BTX1801 is so effective in killing bugs that when compared to Vancomycin and Mupirocin it requires only a fraction of the doses: it is way more powerful than two of the most popular topical antibiotics.
From pages 26 and 29 of the presentation:
HOLY MOLY.pdf
Cheap as chips, page-68
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 31.5¢ | $1.478M | 4.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 107150 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 594669 | 9 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
